Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma

被引:41
作者
Ben Nasr, Hela [1 ]
Chahed, Karim
Mestiri, Souhir
Bouaouina, Noureddine
Snoussi, Kaouther
Chouchane, Lotfi
机构
[1] Fac Med Monastir, Lab Immuno Oncol Mol, Monastir, Tunisia
[2] Inst Super Biotechnol, Monastir, Tunisia
[3] CHU Farhat Hached, Serv Cancerol Radiotherapie, Sousse, Tunisia
关键词
nasopharyngeal; carcinoma; IL-8; polymorphism; genetic susceptibility; prognosis;
D O I
10.1016/j.humimm.2007.06.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Interleukin-8 (IL-8) is an angiogenic chemokine that plays a potent role in both development and progression of many human malignancies including nasopharyngeal carcinoma (NPC). In the present study, we evaluated the susceptibility and prognostic implications of the (-251) T/A genetic variation in IL-8 in NPC. We used the allele-specific polymerase chain reaction to characterize the variation of the IL-8 promoter region for 160 unrelated Tunisian patients with NPC and 169 healthy control subjects. There was a significant association between the homozygotes IL-8 (-251) AA genotype and nasopharyngeal carcinoma (OR = 2.46; P 0.004). The presence of the IL-8 (-251) AA genotype was highly associated with elevated NPC risk for mate patients. A significant association was demonstrated between the IL-8 (-251) AA genotype and the aggressive forms of NPC as defined by large tumor size, lymph node metastasis, and advanced stages. Moreover, the presence of the IL-8 (-251) AA genotype indicated a significant association with decreased overall survival. Our findings suggest that the IL-8 promoter polymorphism is associated with increased nasopharyngeal carcinoma risk, particularly in mates, as well as disease progress, supporting our hypothesis for IL-8 involvement in NPC pathogenesis. (C) 2007 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 48 条
[1]
Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma:: comparison with Hodgkin's disease [J].
Beck, A ;
Päzolt, D ;
Grabenbauer, GG ;
Nicholls, JM ;
Herbst, H ;
Young, LS ;
Niedobitek, G .
JOURNAL OF PATHOLOGY, 2001, 194 (02) :145-151
[2]
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival [J].
Benoy, IH ;
Salgado, R ;
Van Dam, P ;
Geboers, K ;
Van Marck, E ;
Scharpé, S ;
Vermeulen, PB ;
Dirix, LY .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7157-7162
[3]
Interleukin-8 in non-small cell lung carcinoma: Relation with angiogenic pattern and p53 alterations [J].
Boldrini, L ;
Gisfredi, S ;
Ursino, S ;
Lucchi, M ;
Mussi, A ;
Basolo, F ;
Pingitore, R ;
Fontanini, G .
LUNG CANCER, 2005, 50 (03) :309-317
[4]
Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro [J].
Brew, R ;
Erikson, JS ;
West, DC ;
Kinsella, AR ;
Slavin, J ;
Christmas, SE .
CYTOKINE, 2000, 12 (01) :78-85
[5]
Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer [J].
Campa, D ;
Zienolddiny, S ;
Maggini, V ;
Skaug, V ;
Haugen, A ;
Canzian, F .
CARCINOGENESIS, 2004, 25 (02) :229-235
[6]
Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: Indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding [J].
Contasta, I ;
Pellegrini, P ;
Berghella, AM ;
Del Beato, T ;
Canossi, A ;
Maccarone, D ;
Papola, F ;
Adorno, D ;
Casciani, CU .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (06) :385-393
[7]
Cell cycle control in cellular homeostasis during the immune response: Interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules [J].
Contasta, I ;
Pellegrini, P ;
Berghella, AM ;
Adorno, D .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (01) :63-71
[8]
Du HY, 2002, INT J MOL MED, V10, P73
[9]
GREENBLATT MS, 1994, CANCER RES, V54, P4855
[10]
Expression of interleukin-8 receptor A predicts poor outcome in patients with nasopharyngeal carcinoma [J].
Horikawa, T ;
Kaizaki, Y ;
Kato, H ;
Furukawa, M ;
Yoshizaki, T .
LARYNGOSCOPE, 2005, 115 (01) :62-67